nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Carboplatin—ocular cancer	0.704	0.855	CbGbCtD
Trifluoperazine—ABCB1—Dactinomycin—ocular cancer	0.119	0.145	CbGbCtD
Trifluoperazine—EBPL—epithelium—ocular cancer	0.00597	0.0844	CbGeAlD
Trifluoperazine—CALM2—ear—ocular cancer	0.00564	0.0797	CbGeAlD
Trifluoperazine—CALM1—ear—ocular cancer	0.00561	0.0793	CbGeAlD
Trifluoperazine—S100A4—eye—ocular cancer	0.00515	0.0728	CbGeAlD
Trifluoperazine—CALM2—pineal body—ocular cancer	0.00489	0.069	CbGeAlD
Trifluoperazine—CALM1—pineal body—ocular cancer	0.00486	0.0687	CbGeAlD
Trifluoperazine—S100A4—epithelium—ocular cancer	0.00472	0.0666	CbGeAlD
Trifluoperazine—S100A4—lymphoid tissue—ocular cancer	0.00363	0.0513	CbGeAlD
Trifluoperazine—Quetiapine—H1F0—ocular cancer	0.00332	0.537	CrCbGaD
Trifluoperazine—HTR2A—pineal body—ocular cancer	0.00296	0.0419	CbGeAlD
Trifluoperazine—Clozapine—H1F0—ocular cancer	0.00286	0.462	CrCbGaD
Trifluoperazine—CALM3—eye—ocular cancer	0.00189	0.0267	CbGeAlD
Trifluoperazine—CALM3—retina—ocular cancer	0.00187	0.0265	CbGeAlD
Trifluoperazine—SIGMAR1—eye—ocular cancer	0.00169	0.0239	CbGeAlD
Trifluoperazine—CALM2—eye—ocular cancer	0.00148	0.021	CbGeAlD
Trifluoperazine—CALM1—eye—ocular cancer	0.00148	0.0209	CbGeAlD
Trifluoperazine—CALM2—retina—ocular cancer	0.00147	0.0208	CbGeAlD
Trifluoperazine—CALM1—retina—ocular cancer	0.00146	0.0207	CbGeAlD
Trifluoperazine—DRD2—eye—ocular cancer	0.00136	0.0193	CbGeAlD
Trifluoperazine—CALM2—epithelium—ocular cancer	0.00136	0.0192	CbGeAlD
Trifluoperazine—DRD2—retina—ocular cancer	0.00135	0.0191	CbGeAlD
Trifluoperazine—CALM1—epithelium—ocular cancer	0.00135	0.0191	CbGeAlD
Trifluoperazine—ADRA1A—epithelium—ocular cancer	0.00127	0.018	CbGeAlD
Trifluoperazine—HRH1—eye—ocular cancer	0.00108	0.0152	CbGeAlD
Trifluoperazine—CALM2—lymphoid tissue—ocular cancer	0.00105	0.0148	CbGeAlD
Trifluoperazine—CALM1—lymphoid tissue—ocular cancer	0.00104	0.0147	CbGeAlD
Trifluoperazine—HRH1—epithelium—ocular cancer	0.000985	0.0139	CbGeAlD
Trifluoperazine—ADRA1A—lymphoid tissue—ocular cancer	0.00098	0.0139	CbGeAlD
Trifluoperazine—HTR2A—eye—ocular cancer	0.0009	0.0127	CbGeAlD
Trifluoperazine—HTR2A—retina—ocular cancer	0.000892	0.0126	CbGeAlD
Trifluoperazine—HTR2A—epithelium—ocular cancer	0.000823	0.0116	CbGeAlD
Trifluoperazine—ABCB1—retina—ocular cancer	0.000584	0.00826	CbGeAlD
Trifluoperazine—ABCB1—epithelium—ocular cancer	0.000539	0.00762	CbGeAlD
Trifluoperazine—ABCB1—lymphoid tissue—ocular cancer	0.000415	0.00587	CbGeAlD
Trifluoperazine—CALM1—Innate Immune System—CDKN1A—ocular cancer	2.82e-05	0.000282	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAQ—ocular cancer	2.81e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAQ—ocular cancer	2.81e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CDKN1A—ocular cancer	2.8e-05	0.00028	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	2.78e-05	0.000278	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EP300—ocular cancer	2.78e-05	0.000277	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	2.77e-05	0.000277	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CDKN1A—ocular cancer	2.71e-05	0.000271	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CDKN1A—ocular cancer	2.71e-05	0.000271	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by Wnt—AKT1—ocular cancer	2.71e-05	0.000271	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EP300—ocular cancer	2.69e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EP300—ocular cancer	2.69e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TGFB1—ocular cancer	2.68e-05	0.000268	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—E2F1—ocular cancer	2.64e-05	0.000264	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAQ—ocular cancer	2.64e-05	0.000263	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HDAC1—ocular cancer	2.62e-05	0.000262	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by Wnt—AKT1—ocular cancer	2.62e-05	0.000262	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by Wnt—AKT1—ocular cancer	2.62e-05	0.000262	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—E2F1—ocular cancer	2.6e-05	0.00026	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—E2F1—ocular cancer	2.59e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TGFB1—ocular cancer	2.59e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TGFB1—ocular cancer	2.59e-05	0.000259	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—E2F1—ocular cancer	2.55e-05	0.000255	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	2.54e-05	0.000254	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HDAC1—ocular cancer	2.54e-05	0.000253	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HDAC1—ocular cancer	2.54e-05	0.000253	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MDM2—ocular cancer	2.46e-05	0.000245	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN2B—ocular cancer	2.35e-05	0.000235	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—HRAS—ocular cancer	2.28e-05	0.000228	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN2B—ocular cancer	2.27e-05	0.000227	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN2B—ocular cancer	2.27e-05	0.000227	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNA11—ocular cancer	2.26e-05	0.000226	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CDKN1B—ocular cancer	2.24e-05	0.000224	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—AKT1—ocular cancer	2.22e-05	0.000222	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—ocular cancer	2.21e-05	0.00022	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—AKT1—ocular cancer	2.17e-05	0.000217	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—AKT1—ocular cancer	2.17e-05	0.000217	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—E2F1—ocular cancer	2.16e-05	0.000215	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CCND1—ocular cancer	2.14e-05	0.000214	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—ocular cancer	2.13e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—ocular cancer	2.13e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—HRAS—ocular cancer	2.11e-05	0.000211	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAQ—ocular cancer	2.1e-05	0.00021	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—E2F1—ocular cancer	2.09e-05	0.000208	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—E2F1—ocular cancer	2.09e-05	0.000208	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CDKN1A—ocular cancer	2.07e-05	0.000207	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—HRAS—ocular cancer	2.04e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—HRAS—ocular cancer	2.04e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MDM2—ocular cancer	2.02e-05	0.000201	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—AKT1—ocular cancer	2.01e-05	0.000201	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EP300—ocular cancer	1.97e-05	0.000197	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MDM2—ocular cancer	1.95e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MDM2—ocular cancer	1.95e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—HRAS—ocular cancer	1.9e-05	0.00019	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—AKT1—ocular cancer	1.86e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MDM2—ocular cancer	1.86e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CDKN1B—ocular cancer	1.84e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—HRAS—ocular cancer	1.84e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—HRAS—ocular cancer	1.84e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HRAS—ocular cancer	1.82e-05	0.000182	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MDM2—ocular cancer	1.82e-05	0.000182	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MDM2—ocular cancer	1.81e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—AKT1—ocular cancer	1.8e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—AKT1—ocular cancer	1.8e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MDM2—ocular cancer	1.8e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MDM2—ocular cancer	1.8e-05	0.00018	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CDKN1B—ocular cancer	1.78e-05	0.000178	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CDKN1B—ocular cancer	1.78e-05	0.000178	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HRAS—ocular cancer	1.76e-05	0.000176	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HRAS—ocular cancer	1.76e-05	0.000176	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MYC—ocular cancer	1.72e-05	0.000171	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—ocular cancer	1.71e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CDKN1B—ocular cancer	1.7e-05	0.00017	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CDKN1A—ocular cancer	1.7e-05	0.00017	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.7e-05	0.00017	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	1.69e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	1.68e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—AKT1—ocular cancer	1.68e-05	0.000168	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	1.66e-05	0.000166	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	1.65e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CDKN1B—ocular cancer	1.64e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CDKN1B—ocular cancer	1.64e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CDKN1A—ocular cancer	1.64e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CDKN1A—ocular cancer	1.64e-05	0.000164	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	1.64e-05	0.000164	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	1.63e-05	0.000163	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—ocular cancer	1.62e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—ocular cancer	1.62e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EP300—ocular cancer	1.62e-05	0.000161	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—ocular cancer	1.61e-05	0.000161	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MDM2—ocular cancer	1.6e-05	0.000159	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCND1—ocular cancer	1.58e-05	0.000158	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCND1—ocular cancer	1.58e-05	0.000157	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MDM2—ocular cancer	1.57e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CDKN1A—ocular cancer	1.57e-05	0.000157	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MDM2—ocular cancer	1.57e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EP300—ocular cancer	1.56e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EP300—ocular cancer	1.56e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—ocular cancer	1.56e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—ocular cancer	1.56e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MDM2—ocular cancer	1.54e-05	0.000154	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	1.54e-05	0.000154	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	1.53e-05	0.000153	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	1.52e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CDKN1A—ocular cancer	1.52e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CDKN1A—ocular cancer	1.52e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EP300—ocular cancer	1.49e-05	0.000149	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	1.49e-05	0.000149	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	1.48e-05	0.000148	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—HRAS—ocular cancer	1.48e-05	0.000148	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	1.46e-05	0.000146	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EP300—ocular cancer	1.46e-05	0.000146	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	1.46e-05	0.000146	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HRAS—ocular cancer	1.46e-05	0.000145	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EP300—ocular cancer	1.45e-05	0.000145	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EP300—ocular cancer	1.44e-05	0.000144	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EP300—ocular cancer	1.44e-05	0.000144	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	1.44e-05	0.000144	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	1.43e-05	0.000143	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HRAS—ocular cancer	1.43e-05	0.000143	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	1.43e-05	0.000143	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	1.43e-05	0.000143	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	1.42e-05	0.000142	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	1.42e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—ocular cancer	1.41e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	1.41e-05	0.000141	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	1.4e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	1.39e-05	0.000139	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCND1—ocular cancer	1.39e-05	0.000139	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	1.39e-05	0.000139	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCND1—ocular cancer	1.37e-05	0.000137	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCND1—ocular cancer	1.37e-05	0.000136	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HRAS—ocular cancer	1.35e-05	0.000135	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	1.34e-05	0.000134	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCND1—ocular cancer	1.34e-05	0.000134	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	1.34e-05	0.000134	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	1.32e-05	0.000132	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	1.32e-05	0.000132	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—ocular cancer	1.31e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MDM2—ocular cancer	1.3e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—ocular cancer	1.3e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	1.3e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—ocular cancer	1.3e-05	0.00013	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	1.3e-05	0.000129	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	1.29e-05	0.000129	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—ocular cancer	1.29e-05	0.000128	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—ocular cancer	1.28e-05	0.000128	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—ocular cancer	1.27e-05	0.000127	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	1.27e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—ocular cancer	1.26e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—ocular cancer	1.26e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—ocular cancer	1.26e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—ocular cancer	1.25e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—ocular cancer	1.24e-05	0.000123	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—ocular cancer	1.23e-05	0.000123	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—ocular cancer	1.21e-05	0.000121	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—ocular cancer	1.21e-05	0.000121	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—ocular cancer	1.21e-05	0.000121	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—ocular cancer	1.19e-05	0.000119	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—ocular cancer	1.19e-05	0.000119	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—ocular cancer	1.17e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—ocular cancer	1.17e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—ocular cancer	1.15e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—ocular cancer	1.15e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—ocular cancer	1.14e-05	0.000113	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—ocular cancer	1.12e-05	0.000111	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—ocular cancer	1.11e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—ocular cancer	1.11e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—ocular cancer	1.1e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—ocular cancer	1.1e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—ocular cancer	1.1e-05	0.00011	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—ocular cancer	1.1e-05	0.00011	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—ocular cancer	1.09e-05	0.000109	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	1.09e-05	0.000109	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—ocular cancer	1.09e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—ocular cancer	1.08e-05	0.000108	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—ocular cancer	1.07e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—ocular cancer	1.06e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—ocular cancer	1.06e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—ocular cancer	1.05e-05	0.000104	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—ocular cancer	1.04e-05	0.000104	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—ocular cancer	1.04e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—ocular cancer	1.03e-05	0.000103	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—ocular cancer	1.03e-05	0.000103	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—ocular cancer	1.02e-05	0.000102	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—ocular cancer	1.01e-05	0.000101	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—ocular cancer	1.01e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—ocular cancer	9.98e-06	9.96e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—ocular cancer	9.92e-06	9.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—ocular cancer	9.88e-06	9.87e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—ocular cancer	9.88e-06	9.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—ocular cancer	9.77e-06	9.76e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—ocular cancer	9.47e-06	9.46e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—ocular cancer	9.45e-06	9.44e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—ocular cancer	9.45e-06	9.44e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—ocular cancer	9.16e-06	9.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—ocular cancer	9.11e-06	9.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—ocular cancer	9.09e-06	9.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—ocular cancer	9.02e-06	9.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—ocular cancer	9.01e-06	9e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—ocular cancer	8.99e-06	8.98e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—ocular cancer	8.85e-06	8.84e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—ocular cancer	8.82e-06	8.81e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—ocular cancer	8.81e-06	8.8e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—ocular cancer	8.81e-06	8.8e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—ocular cancer	8.81e-06	8.8e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—ocular cancer	8.79e-06	8.78e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—ocular cancer	8.79e-06	8.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—ocular cancer	8.76e-06	8.75e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—ocular cancer	8.76e-06	8.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—ocular cancer	8.73e-06	8.72e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—ocular cancer	8.73e-06	8.72e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—ocular cancer	8.62e-06	8.61e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—ocular cancer	8.6e-06	8.59e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—ocular cancer	8.46e-06	8.45e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	8.44e-06	8.43e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—ocular cancer	7.73e-06	7.72e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—ocular cancer	7.61e-06	7.6e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—ocular cancer	7.59e-06	7.58e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—ocular cancer	7.56e-06	7.55e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—ocular cancer	7.55e-06	7.55e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—ocular cancer	7.48e-06	7.47e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—ocular cancer	7.47e-06	7.46e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	7.45e-06	7.44e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—ocular cancer	7.31e-06	7.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—ocular cancer	7.31e-06	7.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—ocular cancer	7.24e-06	7.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—ocular cancer	7.24e-06	7.23e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—ocular cancer	7.15e-06	7.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—ocular cancer	6.92e-06	6.91e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—ocular cancer	6.92e-06	6.91e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—ocular cancer	6.32e-06	6.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—ocular cancer	6.11e-06	6.1e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—ocular cancer	6.11e-06	6.1e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—ocular cancer	5.73e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—ocular cancer	4.57e-06	4.57e-05	CbGpPWpGaD
